Can China Return to Normalcy While Keeping the Coronavirus in Check?
Public health officials worldwide are watching closely as China addresses COVID-19.
Public health officials worldwide are watching closely as China addresses COVID-19.
In Iran, the fight against the coronavirus is complicated by two other battles: the weight of US-imposed sanctions and the spread of misinformation.
Health authorities in parts of Asia have encouraged all citizens to wear masks in public to prevent the spread of the virus.
George Gao oversees 2,000 employees as the director-general of the Chinese Center for Disease Control and Prevention.
More than 200 million pregnant women around the world are potentially at risk of infection with the new virus.
Researchers are now gearing up to scour the patients’ genomes for DNA variations that explain this mystery.
COVID-19 isn’t the first infectious disease scientists have modeled—Ebola and Zika are recent examples—but never has so much depended on their work.
Denis Rebrikov, a DNA sequencing specialist at the Pirogov Russian National Research Medical University in Moscow, has attracted worldwide scrutiny for plans to fix mutations in human embryos before their implantation.
A Moscow couple considering having a second child shares a genetic mutation that guarantees any son or daughter will have hearing loss.
For many people, CRISPR plus China equals the biophysicist He Jiankui, who infamously used the genome editor last year to alter the DNA of two human embryos that would become twin girls.
What are the potential impacts of modifying genes in humans? Jon Cohen reports on Lulu and Nana, Chinese twins who were genetically modified to be HIV resistant.
Some people who know He and have spoken to Science contend it is time for a more open discussion of how the biophysicist formed his circle of confidants and how the larger circle of trust—the one between the scientific community and the public—broke down.